Scancell Holdings Valuation
| SCNLF Stock | USD 0.19 0.00 0.00% |
Scancell Holdings seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of Scancell Holdings plc from inspecting the company fundamentals such as Shares Outstanding of 818.4 M, return on equity of -0.44, and Operating Margin of (2.06) % as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Scancell Holdings' price fluctuation is out of control at this time. Calculation of the real value of Scancell Holdings plc is based on 3 months time horizon. Increasing Scancell Holdings' time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
The fair value of the Scancell pink sheet is determined by what a typical buyer is willing to pay for full or partial control of Scancell Holdings plc. Since Scancell Holdings is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Scancell Pink Sheet. However, Scancell Holdings' intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.19 | Real 0.15 | Hype 0.19 |
The real value of Scancell Pink Sheet, also known as its intrinsic value, is the underlying worth of Scancell Holdings plc Company, which is reflected in its stock price. It is based on Scancell Holdings' financial performance, growth prospects, management team, or industry conditions. The intrinsic value of Scancell Holdings' stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, or news.
Estimating the potential upside or downside of Scancell Holdings plc helps investors to forecast how Scancell pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Scancell Holdings more accurately as focusing exclusively on Scancell Holdings' fundamentals will not take into account other important factors: About Scancell Holdings Valuation
The pink sheet valuation mechanism determines Scancell Holdings' current worth on a weekly basis. Our valuation model uses a comparative analysis of Scancell Holdings. We calculate exposure to Scancell Holdings's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Scancell Holdings's related companies.Scancell Holdings plc, a clinical stage biopharmaceutical company, engages in the discovery and development of novel vaccines and antibody medicines to treat unmet needs in cancer and infectious diseases. Scancell Holdings plc was founded in 1997 and is based in Oxford, the United Kingdom. Scancell Holdings operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 25 people.
8 Steps to conduct Scancell Holdings' Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates Scancell Holdings' potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct Scancell Holdings' valuation analysis, follow these 8 steps:- Gather financial information: Obtain Scancell Holdings' financial statements, including balance sheets, income statements, and cash flow statements.
- Determine Scancell Holdings' revenue streams: Identify Scancell Holdings' primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research Scancell Holdings' industry and market trends, including the size of the market, growth rate, and competition.
- Establish Scancell Holdings' growth potential: Evaluate Scancell Holdings' management, business model, and growth potential.
- Determine Scancell Holdings' financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate Scancell Holdings' estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
Scancell Holdings Growth Indicators
Investing in growth stocks can be very risky. If the company such as Scancell Holdings does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 815.2 M | |
| Retained Earnings | -49.1 M |
Complementary Tools for Scancell Pink Sheet analysis
When running Scancell Holdings' price analysis, check to measure Scancell Holdings' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scancell Holdings is operating at the current time. Most of Scancell Holdings' value examination focuses on studying past and present price action to predict the probability of Scancell Holdings' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scancell Holdings' price. Additionally, you may evaluate how the addition of Scancell Holdings to your portfolios can decrease your overall portfolio volatility.
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |